Affiliation:
1. College of Health Sciences Oda Bultum University Chiro Ethiopia
2. Department of Medical Laboratory Sciences, Immunology and Molecular Biology Unit, College of Medicine and Health Sciences Bahir Dar University Bahir Dar Ethiopia
3. Department of Public Health, College of Health Sciences Debre Tabor University Debre Tabor Ethiopia
4. Department of Public Health, College of Health Sciences Debre Markos University Debre Markos Ethiopia
Abstract
AbstractBackgroundPreviously, few studies investigated level of adherence to option B+ lifelong antiretroviral therapy (ART) in Ethiopia. However, their findings were inconsistent. Therefore, this review aimed to determine the pooled magnitude of adherence to option B+ lifelong ART and its predictors among human immune virus (HIV)‐positive women in Ethiopia.MethodsA comprehensive web‐based search was conducted using PubMed, Cochrane Library, Science Direct, Google scholar, and African Journals Online databases to retrieve relevant articles. STATA 14 statistical software was used to carry out the meta‐analysis. We used the random effects model to account for the large heterogeneity across included studies. Egger's regression test in conjunction with funnel plot and I2 statistics were utilized to assess publication bias and heterogeneity among included studies respectively.ResultTwelve studies with a total of 2927 study participants were involved in this analysis. The pooled magnitude of adherence to option B+ lifelong ART was 80.72% (95% confidence interval [CI]: 77.05−84.39; I2 = 85.4%). Disclosure of sero‐status (OR 2.58 [95% CI: 1.55−4.3]), receiving counseling (OR 4.93 [95% CI: 3.21−7.57]), attending primary school and above (OR 2.45 [95% CI: 1.31−4.57]), partner support (OR 2.24 [95% CI: 1.11, 4.52]), good knowledge about prevention of mother‐to‐child transmission (PMTCT) (OR 4.22 [95% CI: 2.02−8.84]), taking less time to reach health facility (OR 1.64 [95% CI: 1.13−2.4]), and good relation with care provider (OR 3.24 [95% CI: 1.96−5.34]) were positively associated with adherence. Whereas, fear of stigma and discrimination (OR 0.12 [95% CI: 0.06−0.22]) and advanced disease stage (OR 0.59 [95% CI: 0.37−0.92]) were negatively associated.ConclusionThe level of adherence to option B+ lifelong ART was suboptimal. Strengthened comprehensive counseling and client education on PMTCT, HIV status disclosure, and male partner involvement are important to eliminate mother to child transmission and control the pandemic.
Reference53 articles.
1. UNAIDS.UNAIDS report on the global AIDS epidemic. 2021.
2. Organization WH.PMTCT strategic vision 2010‐2015: preventing mother‐to‐child transmission of HIV to reach the UNGASS and Millennium Development Goals: moving towards the elimination of paediatric HIV December 2009. 2010.
3. DemissieDB BultoGA MekuriaWT DuferaFN. Assessment of antiretroviral therapy Initiation among pregnant women under Option B+ Approach; Viral Load and CD4 Count Outcomes in selected Hospitals of West Zone Oromia Ethiopia: Quantitative Prospective Cohort Study Design. 2019.